Key result
A DNA decoy trapping the DUX4 protein reduced the expression of DUX4 network genes in vitro in FSHD myotubes and in vivo in a DUX4-expressing mouse model.
Why the study?
Facioscapulohumeral dystrophy is characterized by aberrant DUX4 expression acting as a poison protein in muscle, and there is currently no therapeutic solution.
Does a DNA decoy trapping DUX4 reduce the expression of DUX4 network genes in models of Facioscapulohumeral Muscular Dystrophy?
Does a DNA decoy trapping DUX4 reduce the expression of DUX4 network genes in models of Facioscapulohumeral Muscular Dystrophy?
A DNA decoy strategy successfully traps the DUX4 protein and reduces aberrant gene expression in preclinical models of Facioscapulohumeral Muscular Dystrophy.
Provides proof-of-concept for DUX4 decoys in FSHD; hypothesis-generating and requires human trials before any clinical adoption.
Facioscapulohumeral dystrophy (FSHD) is characterized by a loss of repressive epigenetic marks leading to the aberrant expression of the DUX4 transcription factor. In muscle, DUX4 acts as a poison protein though the induction of multiple downstream genes. So far, there is no therapeutic solution for FSHD. Because DUX4 is a transcription factor, we developed an original therapeutic approach, based on a DNA decoy trapping the DUX4 protein, preventing its binding to genomic DNA and thereby blocking the aberrant activation of DUX4's transcriptional network. In vitro , transfection of a DUX4 decoy into FSHD myotubes reduced the expression of the DUX4 network genes. In vivo , both double-stand DNA DUX4 decoys and adeno-associated viruses (AAVs) carrying DUX4 binding sites reduced transcriptional activation of genes downstream of DUX4 in a DUX4-expressing mouse model. Our study demonstrates, both in vitro and in vivo , the feasibility of the decoy strategy and opens new avenues of research.
No takes yet. Share an insight, caveat, or question.
Mariot et al. (2020) studied Facioscapulohumeral Muscular Dystrophy (FSHD). DNA decoy trapping DUX4 was evaluated on Expression of DUX4 network genes. A DNA decoy trapping the DUX4 protein reduced the expression of DUX4 network genes in vitro in FSHD myotubes and in vivo in a DUX4-expressing mouse model.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: